Avicanna (TSX:AVCN) Other Income (Expense) : C$1.40 Mil (TTM As of Dec. 2024)

View and export this data going back to 2019. Start your Free Trial

What is Avicanna Other Income (Expense)?

Avicanna's other income expense for the Avicanna's pretax income for the three months ended in Dec. 2024 was C$1.38 Mil. Its other income expense for the trailing twelve months (TTM) ended in Dec. 2024 was C$1.40 Mil.

Avicanna Other Income (Expense) Historical Data

The historical data trend for Avicanna's Other Income (Expense) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Avicanna Other Income (Expense) Chart

Avicanna Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Other Income (Expense)

Get a 7-Day Free Trial

-15.80

-4.61

-2.65

0.25

1.40

Avicanna Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Other Income (Expense)	Get a 7-Day Free Trial															-0.09	-	-0.02	0.04	1.38

Avicanna Other Income (Expense) Calculation

Other income expense includes minority interest. Minority interest is a significant but non-controlling ownership of less than 50% of a company's voting shares by either an investor or another company.

Other Income (Expense) for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was C$1.40 Mil.

Avicanna (TSX:AVCN) Other Income (Expense) Explanation

Minority interest is reported on the consolidated income statement as a share of profit belonging to minority shareholders.

Avicanna Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Avicanna Inc (TSX:AVCN) » Definitions » Other Income (Expense)

Comparable Companies

Traded in Other Exchanges

AVCNF:USA 0NN:Germany

Address

480 University Avenue, Suite 1502, Toronto, BC, CAN, M5G 1V2

Website

https://www.avicanna.com

Avicanna Inc is an innovative, commercial-stage, and international biopharmaceutical company focused on the development, advancement, and commercialization of evidence-based cannabinoid-based products for the global consumer, as well as medical and pharmaceutical market segments. In global cannabinoid advancements, it conducts most of its research in Canada at its research and development headquarters in JLABS in Toronto, located in the MaRS Discovery District. The company actively collaborates with Canadian academic and medical institutions. Avicanna has established a scientific platform including research and development and clinical development which led to the commercialization of more than twenty products across four main market segments.

Executives

Sheldon Inwentash	10% Security Holder
Threed Capital Inc.	10% Security Holder
Phillip Cardella	Senior Officer
Aras Azadian	Director, Senior Officer
Davender Sohi	Senior Officer
David White	Director
Kyle Lawrence Langstaff	Director or Senior Officer of Insider or Subsidiary (other than in 4,5,6)
Chandra Panchal	Director
Janet Giesselman	Director

Avicanna Headlines

No Headlines